rs3774261

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_004797.4(ADIPOQ):c.215-414A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.56 (AC=122,673) in the gnomAD database across 219,150 control chromosomes, including 35,445 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.627. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 23347 hom., cov: 29)
Exomes 𝑓: 0.59 ( 12098 hom. )

Consequence

ADIPOQ
NM_004797.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00700

Publications

6 publications found
Variant links:
Genes affected
ADIPOQ (HGNC:13633): (adiponectin, C1Q and collagen domain containing) This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010]
ADIPOQ Gene-Disease associations (from GenCC):
  • STAT3-related early-onset multisystem autoimmune disease
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004797.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6275 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_004797.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ADIPOQ NM_004797.4
MANE Select
HGVSc / HGVSpc.215-414A>G
Exon rankIntron 2 of 2
intron
Prot: NP_004788.1UniProt: Q15848A8K660
ADIPOQ NM_001177800.2
HGVSc / HGVSpc.215-414A>G
Exon rankIntron 3 of 3
intron
Prot: NP_001171271.1UniProt: A8K660Q15848
ADIPOQ-AS1 NR_046662.2
HGVSc / HGVSpn.2215+8T>C
Exon rankIntron 3 of 3
splice_regionintron
Prot:

Ensembl Transcripts

ADIPOQ ENST00000320741.7
TSL:1MANE Select
HGVSc / HGVSpc.215-414A>G
Exon rankIntron 2 of 2
intron
Prot: ENSP00000320709.2UniProt: Q15848
ADIPOQ ENST00000444204.2
TSL:1
HGVSc / HGVSpc.215-414A>G
Exon rankIntron 3 of 3
intron
Prot: ENSP00000389814.2UniProt: Q15848
ADIPOQ ENST00000881747.1
HGVSc / HGVSpc.215-414A>G
Exon rankIntron 2 of 2
intron
Prot: ENSP00000551806.1UniProt: Q15848

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.548
AC:82958
Hom:23333
AN:151318
Cov:29
GnomAD4 exome
AF: 0.586
AC:39679
Hom:12098
AN:67714
Cov:0
GnomAD4 genome
AF: 0.548
AC:82994
Hom:23347
AN:151436
Cov:29
TOPMed (Bravo)
AF: 0.534
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.590
AC:129586
Hom:38758
AN:219528
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.518
AC:1213
Hom:311
AN:2342
ChinaMAP Phase 1
AF: 0.441
Denmark Genome
AF: 0.600
AC:180
AN:300
GenomeAsia100K
AF: 0.495
AC:1721
AN:3478
Korea4K (4,157 Koreans)
AF: 0.409
AC:2959
AN:7234
Qatari Genome
AF: 0.420
AC:74
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.410
AC:50332
Hom:10410
AN:122732
Turkish Variome
AF: 0.563
AC:869
Hom:251
AN:1544
UK10K
AF: 0.625
AC:4728
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.439
AC:3937
Hom:870
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.250 636125492 0.176 614634844
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign1.2
BayesDel_noAF
Benign-0.94
CADD
Benign0.57
DANN
Benign0.52
GPN-Star LLR
N/A3.7
GPN-Star score
N/A0.19
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign0.0070
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.